SIAIS178 is primarily utilized in the field of medicinal chemistry and drug discovery, particularly in the development of small molecule inhibitors. It has shown significant potential in targeting specific proteins or enzymes involved in disease pathways, making it a valuable candidate for therapeutic research. Its application is often explored in the treatment of cancers, where it can inhibit the growth and proliferation of tumor cells by interfering with critical cellular processes. Additionally, SIAIS178 is studied for its role in modulating immune responses, which could lead to advancements in treating autoimmune disorders or enhancing the efficacy of immunotherapies. Researchers also investigate its pharmacokinetic properties to optimize its bioavailability and reduce potential side effects, ensuring its suitability for clinical use.